Improve the Performance and Lower the Costs of ODT Drug Applications
J.T.Baker® PanExcea™ MC200G performance excipient from Avantor™ Performance Materials (formerly Mallinckrodt Baker) is engineered to reduce your cost-per-tablet.
J.T.Baker® PanExcea MC200G performance excipient from Avantor Performance Materials (formerly Mallinckrodt Baker) is an orally disintegrating tablet (ODT) building block enabling formulators to develop a direct compression ODT that disintegrates rapidly while offering good taste and texture. PanExcea™ MC200G offers a unique, dense spherical particle shape and morphology to maximize API loading capacity, blend flowability and taste-masking.
An excipient-based solution, PanExcea MC200G is also engineered to reduce cost-per-tablet because it can be produced using standard manufacturing and packaging equipment. This reduces or eliminates the costs of ODT technology licensing and new equipment investment. Read more.
Learn more: www.mallbaker.com/panexcea
Avantor Performance Materials
222 Red School Lane
Phillipsburg, NJ 08865
1-855-AVANTOR (within U.S.)
1-908-859-2151 (outside U.S.)
Fax: 908-859-6905
Meeting Secondary Packaging Challenges of Innovative Delivery Systems for Biologics
February 6th 2025Rapid market growth in biologics is helping the packaging market expand as well, but the complex nature of biologics and the desire for personalized therapies present unique hurdles to make packaging solutions cost-effective and safe for patients.
